NGL(SZ:002836)2022-04-28 16:00Financial Performance - The company's revenue for Q1 2022 was CNY 40,300,742.37, representing a 5.09% increase compared to CNY 38,348,506.17 in the same period last year[4] - Net profit attributable to shareholders was CNY 4,671,687.91, a significant increase of 48.77% from CNY 3,140,108.56 year-on-year[4] - Basic earnings per share increased by 50.00% to CNY 0.03 from CNY 0.02 in the same period last year[4] - Operating profit reached CNY 5,487,813.62, up 45.5% from CNY 3,773,245.90 year-over-year[20] - The net profit for the first quarter of 2022 was CNY 4,671,687.91, an increase of 48.9% compared to CNY 3,140,108.56 in the same period last year[20] - Total revenue from sales of goods and services received was CNY 41,831,234.13, compared to CNY 39,865,580.44 in the previous year[22] Cash Flow and Investments - The net cash flow from operating activities surged by 157.00%, reaching CNY 16,744,273.85 compared to CNY 6,515,174.27 in the previous year[4] - The company reported an investment income of CNY 796,726.03, contrasting with a loss of CNY 45,000.00 in the same period last year[20] - The total cash outflow from investing activities was CNY 40,800,380.58, compared to CNY 572,249.59 in the previous year[23] - The company experienced a net cash flow decrease of CNY 23,249,380.70 in the current period[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 435,987,731.93, up 3.69% from CNY 420,464,680.97 at the end of the previous year[4] - Current assets totaled CNY 222,880,570.54 at the end of Q1 2022, an increase from CNY 203,717,997.34 at the beginning of the year[15] - Total liabilities were CNY 69,065,662.01, compared to CNY 58,214,298.96 at the beginning of the year[17] - The equity attributable to shareholders was CNY 366,922,069.92, slightly up from CNY 362,250,382.01 at the beginning of the year[17] Research and Development - The company reported a 41.50% increase in R&D expenses, totaling CNY 2,747,393.87 compared to CNY 1,941,554.45 in the previous year[9] - Research and development expenses increased to CNY 2,747,393.87, a rise of 41.6% compared to CNY 1,941,554.45 in the previous year[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,205[10] Inventory and Receivables - Accounts receivable increased to CNY 17,590,690.95 from CNY 12,301,942.24 at the beginning of the year[15] - Inventory decreased to CNY 20,870,013.70 from CNY 24,095,543.86 at the beginning of the year[15] Cash and Cash Equivalents - The company’s cash and cash equivalents decreased by 31.75% to CNY 49,987,624.55 due to the purchase of structured deposits[8] - Cash and cash equivalents decreased to CNY 49,987,624.55 from CNY 73,237,005.25 at the beginning of the year[15] - The cash and cash equivalents at the end of the period amounted to CNY 49,987,624.55, compared to CNY 21,046,298.26 at the end of the previous year[24] Operating Costs - The total operating costs for Q1 2022 were CNY 35,418,861.66, compared to CNY 35,038,912.65 in the previous period[19] - The operating cost of goods sold was CNY 27,869,170.26, up from CNY 25,351,328.56 in the previous period[19] Prepayments - The company’s prepayments increased significantly by 347.55% to CNY 177,327.92, indicating a rise in advance payments for goods[8]